Coya Therapeutics Reports Progress on First-in-Class Treg Exosome
Regulatory T cell-derived exosomes (Treg exosomes) have demonstrated strong and consistent therapeutic potential in suppressing inflammation in preclinical models of neurodegenerative diseases Coya Therapeutics, a clinical-stage biotechnology company developing...